APA (7th ed.) Citation

He, T., Zhou, Y., Xu, P., Ling, N., Chen, M., Huang, T., . . . Kang, J. (2022). Safety and antibody response to inactivated COVID‐19 vaccine in patients with chronic hepatitis B virus infection. Liver International, 42(6), 1287. https://doi.org/10.1111/liv.15173

Chicago Style (17th ed.) Citation

He, Taiyu, et al. "Safety and Antibody Response to Inactivated COVID‐19 Vaccine in Patients with Chronic Hepatitis B Virus Infection." Liver International 42, no. 6 (2022): 1287. https://doi.org/10.1111/liv.15173.

MLA (9th ed.) Citation

He, Taiyu, et al. "Safety and Antibody Response to Inactivated COVID‐19 Vaccine in Patients with Chronic Hepatitis B Virus Infection." Liver International, vol. 42, no. 6, 2022, p. 1287, https://doi.org/10.1111/liv.15173.